Vote Scores
Filings read through

CytomX Therapeutics, Inc.: how funds voted at the meeting of 17 Jun 2026

Ticker
CTMX
Meeting
Season
year to 30 June 2026
Filers reporting
173
Ballot items
6

173 filers on Form N-PX reported votes at the CytomX Therapeutics, Inc. meeting of 17 Jun 2026. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 70.4% of the reported votes are for. 18 filers withheld from or voted against at least one nominee.

    178 vote records from 49 filers. 5 of the 47 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 15 fund families
    • For 8
    • Against 2
    • Split or no vote 5
    • Against management 2
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    249 vote records from 172 filers. 7 of the 154 filers that marked the item voted against management. 18 filers gave no management mark.

    • Positions of 21 fund families
    • For 20
    • Against 1
    • Against management 1
  3. Item 3: Frequency of the say-on-pay vote

    One year: 138 filers. Three years: 8 filers. For: 3 filers. Not applicable: 2 filers. 1-year: 2 filers. Abstain: 1 filer.

    248 vote records from 170 filers. 9 of the 151 filers that marked the item voted against management. 19 filers gave no management mark.

    • Positions of 21 fund families
    • Split or no vote 21
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    89 vote records from 49 filers. 0 of the 47 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 15 fund families
    • For 15
  5. Item 5: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    94 vote records from 49 filers. 1 of the 47 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 15 fund families
    • For 15
  6. Item 6: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    178 vote records from 50 filers. 1 of the 48 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 15 fund families
    • For 15

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at CytomX Therapeutics, Inc., meeting of 17 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
BlackRock and iSharesForSplitFor
BNY MellonAgainst, against managementSplitNo report
Charles SchwabForSplitFor
DimensionalForSplit, against managementFor
FidelityForSplitFor
First TrustForSplitFor
Goldman SachsForSplitFor
InvescoForSplitFor
Jackson National fundsForSplit, against managementFor
John Hancock and ManulifeForSplitFor
Morgan Stanley, Eaton Vance and CalvertForSplitNo report
Neuberger BermanForSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitNo report
PGIM and PrudentialForSplitNo report
ProShares and ProFundsForSplitFor
SEIForSplitNo report
State Street and SPDRForSplitFor
VanguardForSplitFor
Victory CapitalForSplitFor
WisdomTreeForSplitFor

Questions

How many filers reported votes at the CytomX Therapeutics, Inc. meeting?
173 Form N-PX filers reported votes at the meeting of 17 Jun 2026. On say-on-pay, 7 of 154 filers that marked the item voted against management (4.5%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. CytomX Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list CytomX Therapeutics, Inc. with a meeting date within three days of 17 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .